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Abstract There is limited information available regarding
the phenotype and function of leukocytes involved in the ear-
liest stages of psoriatic lesion development. In this study, we
examined the presence of diVerent types of leukocytes in
psoriatic point lesions collected at three 1-week interval time
points from a recent and simultaneously formed group of
point lesions. The cells were quantiWed and compared with
K16 expression and epidermal thickness, both typically
increased in this disease and considered as hallmarks. We
found a signiWcant correlation between K16+ cell increment
and the increase in epidermal thickness in the timeframe of
14 days. The change in CD3+, CD4+, and CD8+ T-cell num-
bers in the dermis showed a signiWcant association with these
two features from d7 to d14, whereas in the epidermis only
CD8+ T cells demonstrated a signiWcant correlation. Remark-
ably, the relationship between T cells and disease progression
was preceded by a signiWcant correlation of CD11c+ den-
dritic cells (DCs) with K16 expression and epidermal thick-
ness from baseline onwards. Interestingly, there was also a
numeric correlation of CD11c+ DCs with the CD3+ T-cell
shifts from d7 to d14. A signiWcant correlation was also
found between dermal CD14+ cells and K16 expression from
d7 to d14. BDCA-2+ plasmacytoid DCs were absent in non-
lesional skin, but found at low numbers in most lesions. The
change in plasmacytoid DC or neutrophil numbers did not
correlate with lesion development. In conclusion, our study
suggests a relevant role for T cells, and in particular dermal
CD11c+ DCs, in the earliest stage of psoriatic lesion develop-
ment.
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Introduction
Pronounced thickening of the epidermis with typical long
rete ridges along with marked inWltrations of mononuclear
cells in the papillary dermis are dominant aberrant histolog-
ical features in psoriasis, but many more abnormalities can
be observed in fully developed psoriatic plaques [13, 15,
24]. There are major alterations in the cellular constitution
and extracellular matrix, the proliferation and diVerentia-
tion of keratinocytes are aVected, angiogenesis occurs, and
also cells of innate and acquired immune system are acti-
vated. Despite tremendous eVorts over the last decades to
Wnd the cause of psoriasis, the etiology of this inXammatory
skin disease is still unknown, as it is hard to decide which
features are relevant to the complex pathogenesis and
which are just epiphenomenon.
To investigate the early onset of lesion, etiology is one
approach to unravel the psoriatic pandemonium of multi-
level, simultaneous and reciprocal interactions between
multiple cell types. This approach can provide insight in the
initial series of events that ultimately result in the formation
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444 Arch Dermatol Res (2012) 304:443–449of a full-blown lesion. The evolution of psoriatic lesions
has been studied in various models, such as point lesions
that newly appeared in symptomless skin [2, 6–8, 10, 16,
19], marginal zones of active psoriatic plaques with centrif-
ugal expansion [26], Koebner reactions induced by trau-
matic injury in symptomless skin [1, 4, 9, 17], or
reactivated lesions when relapse occurs after successful
therapy [3, 23]. Symptomless skin from psoriasis patients
transplanted onto immunodeWcient mice also provides a
useful model, as the transplant can convert (either sponta-
neously or induced) into lesional skin with psoriatic hall-
marks [21, 22]. In this study, we have focused on changes
in the presence and distribution of various leukocyte types
in incipient point lesions to estimate alterations that corre-
late signiWcantly with the early-stage development of psoriasis.
Materials and methods
Patients and biopsies
Six patients (25–79 years, mean 52 years; 4 men, 2 women)
with plaque psoriasis were included, who did not receive
any systemic or topical treatment (for 4 and 2 weeks,
respectively) prior to and during the study. This study was
approved by the institutional ethical committee and all
patients gave informed consent before participation. In each
patient, a skin area with several, close-ranged (approxi-
mately 2 cm distance), newly developed point lesions was
selected. One 3-mm biopsy was taken from one point lesion
at baseline (d0) and from adjacent point lesions at d7 and
d14. In Wve patients a biopsy was taken from symptomless
skin. Biopsy samples were snap-frozen in OCT compound
and stored at ¡80 °C.
Antibodies and immunohistochemistry
We have used antibodies against: K16 (Novocastra Labora-
tories Ltd, New Castle, UK), CD11c (BD Pharmingen, San
Diego, CA), CD1a, CD3, CD4, and CD8 and CD14 (Dako
Cytomation, Carpinteria, CA), BDCA-2 (Miltenyi Biotec,
Auburn, CA), and CD66b (BioLegend, San Diego, CA).
The staining procedure was carried out as reported previ-
ously [5].
Digital image and histomorphometric analysis
For each section, overlapping adjacent Welds of images
were acquired at a 200£ magniWcation with a digital cam-
era and a motorized Eclipse 90i microscopy system
equipped with NIS-Elements image analysis program
(Nikon Instruments Inc., Melville, NY) and integrated into
one large image. The resultant color images used in the fol-
lowing quantiWcation analysis were in a 1,280 £ 1,024
pixel RGB format with a 64-bit resolution. For each marker,
the microscope and the camera were calibrated according to
a standardized procedure and these settings were used for
all biopsies.
The K16+ stained area and total epidermal area were
measured. The percentage of K16+ epidermal area was used
in the correlation analysis. For the other stainings, positive
cells were manually counted in the epidermis and dermis
separately. The numbers of positive cells were expressed as
the number of positive cells per square millimeter (mm2) of
epidermis or dermis. The average epidermal thickness was
determined by taking the average epidermal thickness from
Wve diVerent areas of each section measured with NIS-
Element program.
Statistical analysis
The non-parametric Spearman’s correlation (SPSS soft-
ware) was used to assess the statistical diVerence of various
parameters between d0, d7 and d14, and p values of 0.05 or
less were considered signiWcant.
Results
Characterization of epidermal changes
Six psoriasis patients were selected having recently formed
point lesions that had simultaneously developed in a close-
ranged area. Biopsies were taken at baseline and at time
points d7 and d14. Histological evaluation revealed epider-
mal hyperplasia in all six baseline lesional biopsies as com-
pared to non-lesional samples taken from the same patients.
Keratinocyte diVerentiation marker K16 was examined to
assess the activation state of the epidermis [11]. For all six
cases, epidermal thickness and K16 expression showed a
tendency to increase from d0 to d7 (Fig. 1b, c). From d7 to
d14, the levels of both parameters were either sustained or
increased in three biopsies (Fig. 1c, d), while the remaining
three cases showed an unexpected decline (incongruous
with the clinical appearance) in both histological parame-
ters (data not shown). There was a signiWcant correlation
between K16 expression and the change of epidermal thick-
ness in all six cases between d0 and d7 as well as d7 and
d14 (Table 1).
The number of T cells associated with the severity 
of the psoriatic lesions
Similar to non-lesional skin, CD4+ T cells showed a scat-
tered distribution in the epidermal and dermal area in the
early-stage psoriatic lesion at baseline (Fig. 1e vs. f), while123
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in dermis (Fig. 1i vs. j). Although at d7, clearly increased
numbers of epidermal and dermal CD4+ and CD8+ T cells
were observed in all six biopsies as compared to d0
(Figs. 1f vs. g, j vs. k, 2), there was no signiWcant correla-
tion found between the increase of T cells and changes in
K16 expression or epidermal thickness in this time period
(Table 1). Between d7 and d14, a signiWcant correlation
was found between the alteration in dermal CD3+, CD4+ or
CD8+ T cells and changes in epidermal K16 expression or
epidermal thickness (Table 1). In addition, changes in epi-
dermal CD3+ T cells were also found to correlate with
changes in K16 expression, whereas changes in epidermal
CD8+ T cells correlated with epidermal thickness (Table 1).
Dermal CD11c+ dendritic cell increment associated 
with psoriatic lesion progression
At baseline, CD11c+ dendritic cells (DCs) were distributed
predominantly in the dermal perivascular area, in a similar
pattern as in non-lesional skin (Fig. 1m vs. n). The number
of CD11c+ DCs was consistently increased (especially out-
side the perivascular area) in the three cases in which the
lesion development proceeded from d0 to d14 (Figs. 1n–p,
2). The number of CD11c+ DCs declined from d7 to d14 in
the three cases that showed a decline of epidermal thickness
and K16 expression from d7 to d14 (data not shown). The
shift in dermal CD11c+ DC numbers was the only parame-
ter that showed signiWcant correlation with psoriatic lesion
development from d0 through d14 as measured by both epi-
dermal thickness and K16 expression (Table 1). Remark-
ably, the change in CD11c+ DC numbers also correlated
signiWcantly with the changes in numbers of dermal and
epidermal CD3+ T cells from d7 to d14 (Table 1).
The number of epidermal CD1a+ cells in d0 new lesions
was higher (not signiWcant) than in non-lesional baseline
samples (Fig. 1q–t). From d0 to d14, there were variable
non-signiWcant alterations in the number of epidermal and
dermal CD1a+ cells in new lesions (Fig. 2). From d7 to d14,
a signiWcant inverse correlation was found between epider-
mal CD1a+ cells and epidermal thickness (Table 1).
BDCA-2+ plasmacytoid DCs (PDCs) were undetectable in
non-lesional skin (Fig. 2). Small numbers of BDCA-2+
PDCs were seen in most early-stage psoriatic lesions,
mainly in the epidermal–dermal junction, from d0 to d14
without obvious diVerences between these time points. No
correlations were found between BDCA-2+ PDCs and epi-
dermal thickness or K16 expression in this time course. In
Fig. 1 Expression of K16, CD4, 
CD8, CD11c and CD1a in early-
stage psoriatic lesions. Biopsies 
were taken from non-lesional 
skin (day0 NL) and from incipi-
ent psoriatic lesions at baseline 
(day0 L) and 1 (day7 L) and 2 
(day14 L) weeks later. Cryostat 
sections were stained by means 
of immunohistochemistry for 
keratinocyte diVerentiation 
marker K16 (a–d) and for the 
presence of CD4 (e–h) and CD8 
(i–l), CD11c (m–p) and CD1a 
(q–t). Positively stained cells are 
in red color123
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phages were only detected in the dermal area, as was the
case for non-lesional skin. The change in CD14+ cell num-
bers seen in the dermis between d7 and d14 was correlating
with the K16 expression (Table 1; Fig. 2). An occasional or
no CD14+ cell was present in the epidermis in the 14 days
period (data not shown). Only very few CD66b+ neutro-
phils were found in the dermis and epidermis in some early
lesions revealing non-signiWcant diVerences between the
time points (data not shown).
Discussion
We have studied the presence and distribution of various
leukocyte types in recently arisen psoriatic point lesions to
estimate which cells are involved in the onset of psoriatic
plaque formation. The numeric changes in leukocyte popu-
lations were compared with changes in epidermal thickness
and K16 expression, which are two typical features that
represent the activation state of the psoriatic epidermis [1],
and which nicely correlated from baseline to d14 in all our
incipient point lesions. The rise in dermal CD11c+ DC
numbers was the only change that correlated signiWcantly
with the intensiWcation of these two features during the ear-
liest test period d0–d7. Moreover, in the next period (d7–
d14), the signiWcant correlation between alterations of der-
mal CD11c+ DC numbers and activation state of the epider-
mis remained; i.e., the number of DCs raised along with the
increment of epidermal thickness and K16 expression in
three patients, and visa versa, the number of dermal
CD11c+ DCs decreased in the other three patients who
Table 1 Correlation of K16, 
epidermal thickness and 







r p r p
K16 Epidermis vs.  Epi thickness 0.943 0.005 0.943 0.005
CD3 Epidermis vs.  Epi thickness 0.371 0.468 0.771 0.072
vs.  K16 cells 0.2 0.704 0.829 0.042
Dermis vs.  Epi thickness 0.429 0.397 0.886 0.019
vs.  K16 cells 0.657 0.156 0.943 0.005
CD4 Epidermis vs.  Epi thickness 0.257 0.623 0.371 0.468
vs.  K16 cells 0.371 0.468 0.257 0.623
Dermis vs.  Epi thickness 0.314 0.544 0.886 0.019
vs.  K16 cells 0.486 0.329 0.943 0.005
CD8 Epidermis vs.  Epi thickness 0.6 0.208 0.829 0.042
vs.  K16 cells 0.657 0.156 0.771 0.072
Dermis vs.  Epi thickness 0.657 0.156 0.943 0.005
vs.  K16 cells 0.429 0.397 1 <0.001
CD11c Epidermis vs.  Epi thickness 0.2 0.704 0.6 0.208
vs.  K16 cells 0.371 0.468 0.714 0.111
vs.  CD3 cells 0.486 0.329 0.943 0.005
Dermis vs.  Epi thickness 0.943 0.005 0.943 0.005
vs.  K16 cells 0.886 0.019 1 <0.001
vs.  CD3 cells 0.371 0.468 0.943 0.005
CD1a Epidermis vs.  Epi thickness 0.086 0.872 ¡0.886 0.019
vs.  K16 cells 0.029 0.957 ¡0.771 0.072
Dermis vs.  Epi thickness 0.657 0.156 0.429 0.397
vs.  K16 cells 0.486 0.329 0.6 0.208
CD14 Epidermis vs.  Epi thickness ¡0.091 0.864 0.516 0.295
vs.  K16 cells ¡0.03 0.95 0.698 0.123
Dermis vs.  Epi thickness 0.429 0.397 0.771 0.072
vs.  K16 cells 0.657 0.156 0.829 0.042
BDCA-2 Dermis vs.  Epi thickness 0.771 0.072 0.6 0.208
vs.  K16 cells 0.543 0.266 0.657 0.156
Markers indicated in the Wrst 
column are compared with 
changes (vs. ) in epidermal 
thickness (Epi thickness), K16+ 
keratinocyte (K16 cells) or 
CD3+ T cell numbers (CD3 
cells) from d0 to d7 [(d7–d0)] 
or d7 to d14 [(d14–d7)]. All 
other combination of markers 
that are not indicated in this table 
did not reach signiWcant correla-
tion
Statistic signiWcant correlations 
are depicted in bold. 
r = correlation factor, p = value 
of signiWcance123
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One explanation for this decline in epidermal hyperplasia
could be spontaneous remission. In the period d7–d14, the
shift in dermal CD11c+ DC numbers also achieved signiW-
cant correlation with the changes in T-cell numbers.
Although T cells are generally regarded to be essentially
involved in the pathogenesis of psoriasis [13, 15, 24], cor-
relation of the shift in T cell numbers with epidermal thick-
ness and K16 expression was not signiWcant in the earliest
test period d0–d7, but dermal CD4+ and CD8+ T cells
reached signiWcant correlation somewhat later during d7–
d14. The inverse correlation of epidermal CD1a+ cells with
epidermal hyperplasia during d7–d14 is likely due to the
relative rapid-expanding epidermal surrounding compared
to CD1a+ cell numbers. A decrease of CD1a+ cells in early
psoriatic lesions has also been found by others [19],
whereas more numerous CD1a+ cells can be found in the
chronic phase [16]. Altogether, the inXux of CD11c+ DCs
in the dermis showed the most prominent correlation with
the earliest development of psoriatic lesions.
Fig. 2 Count for K16 and leukocytes in early-stage psoriatic lesions.
Biopsies were taken from non-lesional skin (d0 NL) and incipient pso-
riatic lesions at baseline and 1 and 2 weeks later (d0 L, d7 L, d14 L,
respectively). Cryostat sections were stained for K16 expression and
the presence of CD3+, CD4+, and CD8+ T cells, CD1a+ Langerhans
cells and dendritic cells, CD11c+ dendritic cells, CD14+ macrophages
and BDCA-2+ plasmacytoid dendritic cells. The two top rows are
countings of the epidermis while the bottom two rows are dermal cell
numbers. Closed symbols represent cell numbers of the three cases that
showed a decline of epidermal thickness and K16 expression from d7
to d14, while the open symbols represent the three cases that showed
increment of epidermal thickness and K16 expression from d0 to d14.
Statistics of all these numbers are depicted in Table 1
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448 Arch Dermatol Res (2012) 304:443–449Various studies on recently formed psoriatic lesions
have been performed in the pre-immunochemistry era and
were based on hematoxylin and eosin or enzyme staining.
The results in these studies were rather conXicting, as some
reported that the early cellular inWltrate mainly comprises
numerous polymorphonuclear cells [6, 9], whereas in line
with our results, others [2, 10] reported that the early inWl-
trate is mainly mononuclear along with rare occurrence of
polymorphonuclear cells. From the 1980s, when antibodies
became available for immunohistochemistry, the studies on
recently formed psoriatic lesions were primarily focused on
CD4+ and CD8+ T cells and revealed that CD4+ T cells pre-
dominated in the dermis and epidermis in the earliest phase
later followed by preponderance of CD8+ T cells in the epi-
dermis [8, 16, 17, 19]. Our results not only conWrm that the
inWltration of CD4+ and CD8+ T cells correlates with the
development of psoriatic lesions, but also demonstrate that
this elevation in T cells is preceded by an inXux of CD11c+
DCs in the dermis. Although PDCs have been described to
be involved in the early development of psoriasis [14], we
could only demonstrate the presence of these cells in incip-
ient lesions, but could not Wnd a correlation with the early
development of psoriatic lesions. This lack of correlation is
most likely due to the limited number of patients.
Under pathological conditions, the skin is inWltrated by
several diVerent subsets of inXammatory DCs [25],
among others the so-called CD11c+BDCA-1¡ Tip-DCs
[12]. The Tip-DCs have a relevant contribution to the
development and maintenance of psoriatic lesions as they
are not only able to produce proinXammatory and immu-
nomodulatory factors, like TNF- and inducible nitric
oxide synthase, IL-20 and IL-23, but also capable of
polarizing T-cell activation towards Th1/Th17 [12, 18,
28]. In addition, the CD11c+ DC population may also
directly promote epidermal hyperplasia as they produce
large amounts of IL-22 [20]. Moreover, the earliest signs
(within 1–2 weeks) of successful therapy with etanercept
comprise the reduction of multiple inXammatory products
of Tip-DCs [27].
In summary, we have demonstrated that the earliest
development of psoriatic lesions most markedly correlated
with the increment of CD11c+ DCs in the dermis. This sug-
gests that these cells have a relevant role in the generation
of psoriatic lesions and that CD11c+ DCs may serve as tar-
get for therapy.
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